Drug-free sustained remission or spontaneous remission by natural history in rheumatoid arthritis? An unsolved question: comment on the article of Ajeganova et al

被引：6
|
作者：
Zeidler, Henning [1 ]
机构：
[1] Hannover Med Sch, Dept Immunol & Rheumatol, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷 / 07期
关键词：
CLASSIFICATION CRITERIA;
D O I：
10.1136/annrheumdis-2016-210887
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Using Circulating Soluble Serum Mediator Profiles to Understand the Mechanisms Driving Disease Flare and Drug-free Remission in Rheumatoid Arthritis
    Anderson, Amy
    Rayner, Fiona
    Degnan, Abbie
    Wilson, Imogen
    Diboll, Julie
    Sim, Jasmine
    Melville, Andrew
    Siebert, Stefan
    McInnes, Iain
    Goodyear, Carl
    Hilkens, Catharien
    Filer, Andrew
    Raza, Karim
    Buckley, Christopher
    Baker, Kenneth
    Pratt, Arthur
    Isaacs, John
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3387 - 3389
  • [42] Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study
    Motomu Hashimoto
    Moritoshi Furu
    Wararu Yamamoto
    Takanori Fujimura
    Ryota Hara
    Masaki Katayama
    Akira Ohnishi
    Kengo Akashi
    Shuzo Yoshida
    Koji Nagai
    Yonsu Son
    Hideki Amuro
    Toru Hirano
    Kosuke Ebina
    Ryuji Uozumi
    Hiromu Ito
    Masao Tanaka
    Koichiro Ohmura
    Takao Fujii
    Tsuneyo Mimori
    Arthritis Research & Therapy, 20
  • [43] Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study
    Hashimoto, Motomu
    Furu, Moritoshi
    Yamamoto, Wararu
    Fujimura, Takanori
    Hara, Ryota
    Katayama, Masaki
    Ohnishi, Akira
    Akashi, Kengo
    Yoshida, Shuzo
    Nagai, Koji
    Son, Yonsu
    Amuro, Hideki
    Hirano, Toru
    Ebina, Kosuke
    Uozumi, Ryuji
    Ito, Hiromu
    Tanaka, Masao
    Ohmura, Koichiro
    Fujii, Takao
    Mimori, Tsuneyo
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [44] On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis (vol 38, pg 2225, 2018)
    Bykerk, Vivian P.
    Burmester, Gerd R.
    Combe, Bernard G.
    Furst, Daniel E.
    Huizinga, Tom W. J.
    Ahmad, Harris A.
    Emery, Paul
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (05) : 945 - 945
  • [45] Clinical contrasts with the American College of Rheumatology/European League Against Rheumatism provisional definitions of remission in rheumatoid arthritis for clinical trials: comment on the article by Felson et al
    Rotar, Ziga
    Praprotnik, Sonja
    Tomsic, Matija
    ARTHRITIS AND RHEUMATISM, 2011, 63 (11): : 3642 - 3643
  • [46] Response to: 'Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al' by Berkhout et al
    Tanaka, Yoshiya
    Oba, Koji
    Takeuchi, Tsutomu
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (11)
  • [47] Immunoglobulin free light chain levels and rituximab response in rheumatoid arthritis: Comment on the article by Sellam et al
    Tekstra, Janneke
    van Roon, Joel
    Kormelink, Tom Groot
    Redegeld, Frank
    ARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 4034 - 4035
  • [48] No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission
    Bozzalla Cassione, Emanuele
    Mansoubi, Mehrad
    Mazzucchelli, Iolanda
    Luvaro, Terenzj
    De Stefano, Ludovico
    Xoxi, Blerina
    Grignaschi, Silvia
    Bugatti, Serena
    Montecucco, Carlomaurizio
    Manzo, Antonio
    CLINICAL RHEUMATOLOGY, 2022, 41 (08) : 2605 - 2607
  • [49] No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission
    Emanuele Bozzalla Cassione
    Mehrad Mansoubi
    Iolanda Mazzucchelli
    Terenzj Luvaro
    Ludovico De Stefano
    Blerina Xoxi
    Silvia Grignaschi
    Serena Bugatti
    Carlomaurizio Montecucco
    Antonio Manzo
    Clinical Rheumatology, 2022, 41 : 2605 - 2607
  • [50] Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al
    Berkhout, Lea C.
    l'Ami, Merel J.
    Wolbink, Gerrit Jan
    Rispens, Theo
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (11)
12345